About a year after QuintilesIMS was born from a megamerger between Quintiles and IMS Health, the contract research giant has decided to turn the page.

Bioclinica is looking to broaden its reach with the purchase of MDDX Research & Informatics.

Imricor Medical Systems and Mirtle Medical are combining their offerings to create an alternative to x-ray guided ablation.

Major CRO player PPD has won a lucrative seven-year government contract in infectious disease.

Medical devices-focused CRO Factory has expanded in North America with the acquisition of Milestone.

Charles River builds in vitro 3D tumor microtissues derived from its PDXs using InSphero's 3D cell culture solutions.

A recent regulation proposed by the New Jersey Attorney General might affect the state's availability of clinical trials.

Germany’s Evotec has penned another deal amid a stream of R&D pacts over the past year, this time with PARP player Tesaro.